Latest Smith, Kline & French Stories
RESEARCH TRIANGLE PARK, N.C., June 2 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products SereventÂ® and AdvairÂ®.
CAMBRIDGE, Mass., March 30 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has appointed Tamar D. Howson to its Board of Directors.
LONDON and PHILADELPHIA, March 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that it has re-submitted the supplemental New Drug Application (sNDA) for AvodartÂ® (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease to the US Food and Drug Administration (FDA).
WEST PALM BEACH, Fla., March 29 /PRNewswire/ -- The Cosmetic Bootcamp is pleased to announce an expanded program for its June 2010 meeting at The Broodmoor in Colorado Springs.
GlaxoSmithKline Continues to Blame Patients Crippled by Poligrip HOUSTON, March 3 /PRNewswire-USNewswire/ -- Pharmaceutical giant, GlaxoSmithKline (GSK), has taken the extraordinary step of warning doctors about the dangers posed by its denture cream, while continuing to blame and mislead patients crippled by its products.
Because the safety and health of our consumers is our primary concern, GlaxoSmithKline (GSK) Consumer Healthcare is issuing a Consumer Advisory warning consumers about the potential health risks associated with long-term excessive use of zinc-containing denture adhesives.
Untold Numbers of Consumers Still Left Disabled By Its Products WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- GlaxoSmithKline, the maker of popular denture adhesives Poligrip and Super Poligrip, announced today that it will remove zinc from all of its denture adhesive products.
PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- On Thursday, February 4, 2010, GlaxoSmithKline plc will announce its full year financial results for the year ended December 31, 2009.
CINCINNATI, Dec. 22 /PRNewswire/ -- Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics.
PARSIPPANY, N.J. and ANN ARBOR, Mich., Dec.